- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04139356
The Effect of Spontaneous Respiration on Pulse-oximetry Measurements
October 23, 2019 updated by: Uriel Chavarria-Martinez, Universidad Autonoma de Nuevo Leon
The Effect of Spontaneous Respiration on Pulse-oximetry Measurements and Analysis of Variability Mechanisms
This is a study designed to measure, characterize and describe changes on pulse-oxymetry values produced as a result of deep breaths in patients with stable chronic hypoxemic respiratory failure.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
There is no standard way of measuring rest pulse-oxymetry in terms of depth of respiration.
Rest pulse-oxymetry values are used in the clinical setting to make therapeutic decisions regarding the need of supplemental oxygen.
The primary goal of this study is to measure the change of pulse-oxymetry values during an experimental protocol of 10 deep breaths during one minute in patients with chronic hypoxemia.
45 patients will be studied in this first phase.
In a second phase, secondary goals will be to measure Vd/Vt vent, noninvasive cardiac output and CT densitometry during the same deep breaths protocol in a subset of 13 patients with the grater increase observed in the first phase of study.
Study Type
Interventional
Enrollment (Anticipated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Uriel Chavarria, MD
- Phone Number: +528183482018
- Email: uriel_chavarria@hotmail.com
Study Locations
-
-
Nuevo Leon
-
Monterrey, Nuevo Leon, Mexico, 64630
- Recruiting
- Facultad de Medicina y Hospital Universitario UANL
-
Contact:
- Uriel Chavarria, MD
- Phone Number: +528183482018
- Email: uriel_chavarria@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with chronic lung disease causing rest hypoxemia, with rest SpO2 values equal or lower than 94% on room air
- Ambulatory patients capable of performing 6 min walking test
- Patients older than 18 years old.
Exclusion Criteria:
- Patients with significant collagen disease causing Raynaud phenomenon.
- Patients with hypothermia lower than 35 degrees Celsius
- Patients with rest SpO2 values equal or lower than 80% on room air
- Patients unable to perform PFTs
- Patients unable to complete 6 min walking test without supp O2.
- Patients unable to perform experimental deep breaths on CT scan
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients with rest O2 desaturation
Patient will undergo an experimental protocol consisting of 10 deep inspirations to measure and characterize changes on pulse-oxymetry values
|
Patients will undergo a 6 minutes protocol.
Baseline: 1 minute normal breaths.
Intervention: 1 minute with 10 deep breaths, 1 each 6 secs.
Pulse-oxymetry will be continuously recorded.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in O2 saturation
Time Frame: Lenght of experimental protocol: 6 minutes.
|
A Saturation change greater than 4% will be considered significant
|
Lenght of experimental protocol: 6 minutes.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vd/VT
Time Frame: Lenght of experimental protocol: 6 minutes.
|
In a subset of 13 patients with the greater increase on O2Sat, Vd/Vt will be measured during the same protocol
|
Lenght of experimental protocol: 6 minutes.
|
Cardiac output (CO)
Time Frame: Lenght of experimental protocol: 6 minutes.
|
In a subset of 13 patients with the greater increase on O2Sat, CO will be measured during the same protocol
|
Lenght of experimental protocol: 6 minutes.
|
CT recruitment
Time Frame: Lenght of experimental protocol: 6 minutes.
|
In a subset of 13 patients with the greater increase on O2Sat, CT recruitment will be calculated using densitometry values during the same protocol
|
Lenght of experimental protocol: 6 minutes.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Uriel Chavarria, MD, Facultad de Medicina y Hospital Universitario UANL
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2019
Primary Completion (Anticipated)
November 15, 2019
Study Completion (Anticipated)
December 15, 2019
Study Registration Dates
First Submitted
October 23, 2019
First Submitted That Met QC Criteria
October 23, 2019
First Posted (Actual)
October 25, 2019
Study Record Updates
Last Update Posted (Actual)
October 25, 2019
Last Update Submitted That Met QC Criteria
October 23, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UAutonomaNL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Interstitial Lung Disease
-
Boehringer IngelheimNo longer availableLung Diseases, Interstitial (in Pediatric Populations) | Childhood Interstitial Lung Disease (chILD)
-
Matthias GrieseSuspendedInterstitial Lung Disease | Diffuse Parenchymal Lung Disease | Children´s Interstitial Lung DiseaseGermany
-
University of AlbertaAlberta Boehringer Ingelheim CollaborationNot yet recruitingFibrotic Interstitial Lung Disease
-
Monash UniversityRecruitingFibrotic Interstitial Lung DiseaseAustralia
-
Heidelberg UniversityHelmholtz Zentrum München; University of Giessen; Lungenfibrose e.V.; German Center... and other collaboratorsCompletedInterstitial Lung Disease (ILD)Germany
-
University of California, San FranciscoTerminatedFibrotic Interstitial Lung DiseaseUnited States
-
University of AarhusAarhus University HospitalNot yet recruitingProgressive Fibrosing Interstitial Lung DiseaseDenmark
-
West Virginia UniversityNot yet recruitingProgressive Fibrosing Interstitial Lung DiseaseUnited States
-
Saglik Bilimleri UniversitesiRecruitingTelerehabilitation | Fibrosing Interstitial Lung DiseaseTurkey
Clinical Trials on Deep breaths
-
Riphah International UniversityCompletedCoronary Artery Bypass GraftPakistan
-
Thomas Jefferson UniversityCompletedPre-oxygenation
-
University of MinnesotaUniversity of Colorado, Denver; United States Department of DefenseCompletedAcute Respiratory Distress SyndromeUnited States
-
King's College LondonKing's College Hospital NHS TrustCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast Cancer | Fatigue | Hot Flashes | Sleep DisordersUnited States
-
Ospedale San RaffaeleActive, not recruitingRespiratory Failure | Motor Neuron Disease | Amyotrophic Lateral SclerosisItaly
-
University of UtahNational Institute of Nursing Research (NINR)Completed
-
Rigshospitalet, DenmarkUnknownRespiratory Distress Syndrome, Newborn | Bronchopulmonary Dysplasia | Ventilator Induced Lung InjuryDenmark
-
Rigshospitalet, DenmarkCompletedBronchopulmonary Dysplasia | Ventilator-Induced Lung Injury | Respiratory Distress Syndrome In Premature Infants | Functional Residual CapacityAustralia
-
The Netherlands Cancer InstituteRecruiting